Title | Relation of Diabetes Mellitus to Incident Dementia in Patients With Atrial Fibrillation (from the Atherosclerosis Risk in Communities Study). |
Publication Type | Journal Article |
Year of Publication | 2022 |
Authors | Jiayaspathi A, Chen LYee, Selvin E, Gottesman RF, Knopman DS, Mosley TH, Norby FL, Alonso A |
Journal | Am J Cardiol |
Volume | 165 |
Pagination | 51-57 |
Date Published | 2022 02 15 |
ISSN | 1879-1913 |
Keywords | Aged, Aged, 80 and over, Atrial Fibrillation, Blood Glucose, Cohort Studies, Dementia, Diabetes Mellitus, Female, Glycated Hemoglobin A, Humans, Incidence, Male, Multivariate Analysis, Prevalence, Proportional Hazards Models |
Abstract | The association of diabetes mellitus (DM), an established risk factor for dementia in the general population, with incident dementia in patients with atrial fibrillation (AF) has not been explored. We performed a cohort study where we identified subjects with incident AF in the Atherosclerosis Risk in Communities cohort (1987 to 2017) and determined their DM status, fasting blood glucose before AF diagnosis and hemoglobin A1c levels using information from the closest previous study visit. Incident dementia was expert adjudicated using information from cognitive assessments, informant interviews and hospitalization surveillance. We calculated hazard ratios (HRs) and 95% confidence intervals (CIs) of incident dementia for each level of exposure using Cox models and adjusting for potential confounders. We analyzed 3,020 patients with AF in the Atherosclerosis Risk in Communities cohort (808 with DM) and 530 had incident dementia after a mean follow-up of 5.3 years after AF diagnosis. After multivariable adjustment, patients with AF with prevalent DM had higher rates of dementia than those without DM, HR 1.45 (95% CI 1.16 to 1.80). A value of hemoglobin A1c ≥6.5% was associated with a HR 1.29 (95% CI 0.97 to 1.71) of dementia. However, fasting blood glucose was not associated with rates of dementia independent of DM status. In conclusion, DM was associated with higher rates of dementia in patients with AF. DM prevention and control could be a promising avenue for reducing risk of dementia in AF. |
DOI | 10.1016/j.amjcard.2021.11.005 |
Alternate Journal | Am J Cardiol |
PubMed ID | 34887073 |
PubMed Central ID | PMC8766899 |
Grant List | U01 HL096812 / HL / NHLBI NIH HHS / United States K24 HL152440 / HL / NHLBI NIH HHS / United States R01 DK089174 / DK / NIDDK NIH HHS / United States U01 HL096902 / HL / NHLBI NIH HHS / United States 16EIA26410001 / AHA / American Heart Association-American Stroke Association / United States HHSN268201700002C / HL / NHLBI NIH HHS / United States HHSN268201700001I / HL / NHLBI NIH HHS / United States U01 HL096814 / HL / NHLBI NIH HHS / United States R01 HL070825 / HL / NHLBI NIH HHS / United States HHSN268201700003I / HL / NHLBI NIH HHS / United States P30 AG066511 / AG / NIA NIH HHS / United States U01 HL096917 / HL / NHLBI NIH HHS / United States K24 HL148521 / HL / NHLBI NIH HHS / United States HHSN268201700004I / HL / NHLBI NIH HHS / United States HHSN268201700005C / HL / NHLBI NIH HHS / United States HHSN268201700001C / HL / NHLBI NIH HHS / United States HHSN268201700003C / HL / NHLBI NIH HHS / United States U01 HL096899 / HL / NHLBI NIH HHS / United States HHSN268201700004C / HL / NHLBI NIH HHS / United States HHSN268201700002I / HL / NHLBI NIH HHS / United States HHSN268201700005I / HL / NHLBI NIH HHS / United States |